Go to article
Posted by CoV Report on June 8, 2021 9:02 amTags: Categories: Global Stories
Pfizer Inc said on Tuesday it will start a large study to test its COVID-19 vaccine in children below 12 and selected a dosing regime for the trial.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
< The Coronavirus Report home
Everything you need to know to stay updated on the Coronavirus
Leave a Reply